Hsa-miR-1248 suppressed the proliferation, invasion and migration of colorectal cancer cells via inhibiting PSMD10
Open Access
- 26 August 2022
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 22 (1) , 1-11
Abstract
Background: Lymph node metastasis (LNM) is a critical event during the colorectal cancer (CRC) development and is indicative of poor prognosis. Identification of molecular markers of LNM may facilitate better therapeutic decision-making.Methods: Six pairs of CRC tissues and corresponding adjacent tissues [3 pairs diagnosed as pT1N0M0 (M_Low group) and 3 pairs diagnosed as pT4N2M0 (M_High group)] collected from CRC patients who underwent surgical resection were used. MicroRNA sequencing was performed to screen differential microRNAs involved in CRC LNM. The selected microRNAs were validated in CRC tissues and cell lines using qRT-PCR. The functions of candidate hsa-miR-1248 were evaluated by CCK-8, colony formation, and Transwell assay. The binding of hsa-miR-1248 with its target PSMD10 was confirmed by luciferase activity assay, and the expression of PSMD10 in tissues was detected by droplet digital polymerase chain reaction.Results: Ninety-five miRNAs were downregulated in carcinoma tissues (M_Low and M_high groups) compared with the normal group. Their expression in M_High group was significantly lower compared with M_Low group. The top 3 were hsa-miR-635, hsa-miR-1248, and hsa-miR-668-3p. After validation in tissues/cell lines, only hsa- hsa-miR-1248 was decreased in high metastatic tissues or SW620 cells compared to low metastatic tissues or SW480 cells. Hsa-miR-1248 was found to inhibit CRC cell viability, proliferation, invasion, and migration. The tumor suppressor effect of has-miR-1248 in CRC cells was attenuated or enhanced by up-regulating or down-regulating PSMD10, respectively.Conclusion: Hsa-miR-1248 may act as a tumor suppressor gene in CRC by targeting and inhibiting PSMD10, which provides a clue for CRC treatment.Keywords
All Related Versions
This publication has 27 references indexed in Scilit:
- The Oncoprotein Gankyrin/PSMD10 as a Target of Cancer Therapy2019
- miR-214 regulates papillary thyroid carcinoma cell proliferation and metastasis by targeting PSMD10International Journal of Molecular Medicine, 2018
- A MicroRNA Signature Associated With Metastasis of T1 Colorectal Cancers to Lymph NodesGastroenterology, 2018
- MicroRNA‐1254 inhibits the migration of colon adenocarcinoma cells by targeting PSMD10Journal of Digestive Diseases, 2017
- MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationshipNature Reviews Genetics, 2012
- Lymph Node Micrometastases and Isolated Tumor Cells Influence Survival in Stage I and II Colon CancerDiseases of the Colon & Rectum, 2011
- Overexpression of a novel gene gankyrin correlates with the malignant phenotype of colorectal cancerCancer Biology & Therapy, 2010
- MicroRNAs and Cancer: Short RNAs Go a Long WayCell, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Lymph Node Evaluation in Colorectal Cancer Patients: A Population-Based StudyJNCI: Journal of the National Cancer Institute, 2005